How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,267 results for

Long-Acting Reversible Contraception

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1261. Contraception - General Overview

in 2013-2014 (and therefore involving a more limited group of the population) published by the Health and Social Care Information Centre (HSCIC) showed: [ ] 1.34 million people accessed sexual and reproductive health services in the one-year time frame, of whom 89% were women. The service was mostly used by women aged 18-19. Oral contraceptives were the most commonly used form of contraception across all ages, used by 47% of women. 31% used long-acting reversible contraceptives (LARCS), an increase (...) -containing pills which have a 12-hour window.) There is increased risk of functional ovarian cysts and the small possibility of an increased risk of breast cancer. Where pregnancy does occur on the POCP, there may be a slightly increased risk that this is ectopic (estimated 1 in 10). Levonelle® is progestogen-only Progestogen-only injectable contraceptives [ ] For more comprehensive information, see the separate article A progestogen-only injection is a long-acting, reversible contraceptive. A synthetic

2008 Mentor

1262. Attitudes of women in Scotland to contraception: a qualitative study to explore the acceptability of long-acting methods. Full Text available with Trip Pro

Attitudes of women in Scotland to contraception: a qualitative study to explore the acceptability of long-acting methods. Long-acting reversible contraception (LARC) (i.e. injections, implants and intrauterine methods) has the potential to reduce unintended pregnancies but in the UK these methods are under-used. To inform a campaign planned to increase awareness of LARC, eight focus discussion groups were held with 55 women in two cities in Scotland, UK. Trained interviewers sought spontaneous (...) but giving more information about ease of use, reversibility, effects on weight and the positive experiences of other women, as well as describing these methods as lasting rather than long-acting, may help improve acceptability.

2008 Journal of Family Planning and Reproductive Health Care

1263. Long-acting contraceptives in adolescents. (Abstract)

used in adolescents, intrauterine devices offer selected adolescents convenient, highly effective, safe birth control. Use of the progestin-releasing intrauterine device (Mirena) is also associated with important non-contraceptive benefits.The efficacy and convenience associated with long-acting contraceptives make them indispensable for adolescent patients. This review will help clinicians guide teenage patients towards sound contraceptive choices and the successful long-term use of injectable (...) Long-acting contraceptives in adolescents. To help clinicians guide adolescent patients to sound choices regarding long-acting contraceptives. The safety, side effects and non-contraceptive benefits of injectable, implantable and intrauterine contraception are detailed.The use of depot medroxyprogesterone acetate contraceptive injections has been associated with declines in teenage pregnancies in the United States. Although the US Food and Drug Administration has placed a black box warning

2007 Current Opinion in Obstetrics and Gynecology

1264. Attitudes towards long-acting reversible methods of contraception in general practice in the UK. (Abstract)

Attitudes towards long-acting reversible methods of contraception in general practice in the UK. Recently published national guidance in England recommended that increased use of long-acting reversible methods of contraception could reduce unintended pregnancy rates. Usage rates of long-acting reversible methods of contraception in the UK are currently low. Since these methods require medical intervention, attitudes of professionals are important determinants of prevalence of use.A (...) questionnaire survey was conducted of 321 health professionals working in general practice which sought practitioner views on safety, efficacy and acceptability of contraceptive methods, and on the feasibility and desirability of prescribing long-acting methods.A high proportion of practitioners (80.2%) endorsed the role of LARC in preventing teenage pregnancy, but fewer than half (47.1%) saw them as returning to favor. The combined oral contraceptive pill is still the mainstay of prescriptions. Lack

2007 Contraception

1265. An effective hormonal male contraceptive using testosterone undecanoate with oral or injectable norethisterone preparations. Full Text available with Trip Pro

An effective hormonal male contraceptive using testosterone undecanoate with oral or injectable norethisterone preparations. Suppression of spermatogenesis to azoospermia is the goal of hormonal male contraception based on T combined with gestagens. The combination of the long-acting T, ester testosterone undecanoate (TU), with norethisterone (NET) enanthate (E) showed high efficacy. In the present study, we tested the validity of this approach by varying the NET dose and mode of application (...) (NETA) from wk 0 to 24 (group III). In all groups marked suppression of gonadotropins resulted in a significant decrease of spermatogenesis and azoospermia in 13/14, 11/12, and 12/14 men in groups I to III, respectively. The remaining men all had less than 1 million sperm/ml. Reversible side effects included increase in body weight, erythrocytes, hemoglobin, and hematocrit and decrease in high-density lipoprotein cholesterol and alkaline phosphatase in all groups and increase in liver enzymes

2002 The Journal of clinical endocrinology and metabolism Controlled trial quality: uncertain

1266. Suppression of spermatogenesis by etonogestrel implants with depot testosterone: potential for long-acting male contraception. Full Text available with Trip Pro

, hematocrit, or high-density lipoprotein cholesterol concentrations during treatment. These data demonstrate that etonogestrel implants with depot testosterone provide effective suppression of spermatogenesis with reduced metabolic effects and are, therefore, a promising approach to the development of long-acting yet reversible male contraception. (...) Suppression of spermatogenesis by etonogestrel implants with depot testosterone: potential for long-acting male contraception. The coadministration of a progestogen with testosterone increases the degree of suppression of spermatogenesis and is one approach to the development of hormonal male contraception. Depot formulations may allow a reduction in dosage, minimizing adverse effects. We have investigated the effects of a sc implant containing the progestogen etonogestrel (Implanon) with depot

2002 The Journal of clinical endocrinology and metabolism Controlled trial quality: uncertain

1267. A clinical trial of 7 alpha-methyl-19-nortestosterone implants for possible use as a long-acting contraceptive for men. Full Text available with Trip Pro

A clinical trial of 7 alpha-methyl-19-nortestosterone implants for possible use as a long-acting contraceptive for men. Several preparations of testosterone and its esters are being investigated alone or in combination with other gonadotropin-suppressing agents as possible antifertility agents for men. We studied the effectiveness of 7 alpha-methyl-19-nortestosterone (MENT) as an antispermatogenic agent in men. MENT has been shown to be more potent than testosterone and to be resistant to 5 (...) in the 2-implant group became oligozoospermic, 2 of whom reached azoospermia. Eight subjects in the 4-implant group reached azoospermia, with 1 exhibiting oligozoospermia, whereas 2 were nonresponders. Side effects generally seen with androgen administration, such as increases in erythrocyte count, hematocrit, and hemoglobin and a decrease in SHBG, were also seen in this study and were reversible. Changes in lipid parameters were moderate and transient. Liver enzymes showed small changes. This study

2003 The Journal of clinical endocrinology and metabolism Controlled trial quality: uncertain

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>